Showing results (121-130 of 219) with videos related to
Sort By:
Pageof 22
Ecohealth|November 13, 2019
Mercury in Populations of River Dolphins of the Amazon and Orinoco BasinsF Mosquera-Guerra, F Trujillo, D Parks, et al.EMBO Molecular Medicine|January 6, 2019
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanomaVivian Chua, Marlana Orloff, Jessica Lf Teh, et al.Human Pathology|December 27, 2014
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironmentSandra P D'Angelo, Alexander N Shoushtari, Narasimhan P Agaram, et al.Oncoimmunology|January 4, 2018
Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trialDavid J Chung, Richard D Carvajal, Michael A Postow, et al.European Radiology|September 30, 2020
Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trialFiras S Ahmed, Laurent Dercle, Gregory V Goldmacher, et al.Annals of Surgical Oncology|January 19, 2013
Locoregional lymphadenectomy in the surgical management of anorectal melanomaDaniel R Perez, Atthaphorn Trakarnsanga, Jinru Shia, et al.Nature Reviews. Disease Primers|April 11, 2020
Uveal melanomaMartine J Jager, Carol L Shields, Colleen M Cebulla, et al.Melanoma Research|January 23, 2016
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanomaAlexander N Shoushtari, Leonard T Ong, Heiko Schoder, et al.Journal of Neurosurgery. Case Lessons|March 10, 2025
Intramedullary primary spinal cord melanoma: illustrative caseAkash Mishra, Danielle Golub, Daniel Schneider, et al.Investigational New Drugs|November 12, 2017
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanomaSandra P D'Angelo, Omid A Hamid, Ahmad Tarhini, et al.Pageof 22